+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Decreased spinal fluid monoamine metabolites and norepinephrine in schizophrenic patients with brain atrophy



Decreased spinal fluid monoamine metabolites and norepinephrine in schizophrenic patients with brain atrophy



Beckmann, H And P Riederer (Ed ) Pathochemical Markers in Major Psychoses; Symposium, Vienna, Austria, July 1983 X+158p Springer-Verlag: New York, N Y , Usa; Berlin, West Germany Illus 88-95




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 028050333

Download citation: RISBibTeXText


Related references

Monoamine metabolite levels in cerebrospinal fluid and brain atrophy in lobotomized schizophrenic patients. Annals of Clinical Research 11(1): 25-29, 1979

Monoamine metabolites in the cerebrospinal fluid in infantile spinal muscular atrophy. Neuroreport 5(8): 898-900, 1994

Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers. Psychiatry Research 9(4): 301-308, 1983

Effect of ischemia on monoamine metabolism. Brain monoamine metabolites in cerebrospinal fluid of patients with recent cerebral infarction. NeuropatologiaPolska20(1-2):97, 1982

Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. British Journal of Psychiatry 147: 276-282, 1985

Neuropsychological test performance, brain morphological measures and CSF monoamine metabolites in schizophrenic patients. Acta Psychiatrica Scandinavica 74(3): 292-301, 1986

Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor. Biological Psychiatry 14(3): 509-523, 1979

Spinal fluid monoamine metabolites and anti-cytomegalovirus antibodies and brain scan evaluation in schizophrenia. Psychopharmacology Bulletin 20(3): 519-522, 1984

Cerebro spinal fluid concentration of thioridazine and its metabolites in schizophrenic patients. Research Communications in Psychology Psychiatry & Behavior 3(2): 83-87, 1978

Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients. Biological Psychiatry 56(6): 418-426, 2004

Dopamine, noradrenaline and serotonin spinal fluid metabolites in temporal lobe epileptic patients with schizophrenic symptomatology. European Neurology 18(1): 15-18, 1979

Monoamine metabolites in successive samples of spinal fluid. A comparison between healthy volunteers and patients with multiple sclerosis. Acta Neurologica Scandinavica 63(4): 247-254, 1981

Cerebro spinal fluid mono amine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dys kinesia. Neurochemical Research 3(5): 654, 1978

Smooth pursuit eye movements clinical symptoms cerebro spinal fluid metabolites and skin conductance habituation in schizophrenic patients. Biological Psychiatry 18(9): 971-988, 1983

CSF monoamine metabolites in schizophrenic patients. Acta Psychiatrica Scandinavica 66(5): 350-360, 1982